InsidersTradesSigma
Follow the 메디포스트 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 메디포스트 has published 1 insider filings. Market capitalisation: €339.7bn. The latest transaction was filed on 12 March 2026 (Other). Among the most active insiders: 메디포스트. The full history is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
메디포스트 is a company in the health and pharmaceutical sector, listed on the XKRX market. It focuses on the development of cell therapies and biopharmaceutical products.